ImmunologyJournal for ImmunoTherapy of CancerPeer-reviewed
Oncolytic HSV-IL27 expression improves CD8 T cell function and therapeutic activity in syngeneic glioma models
Alexia K. Martin, Jack Hedberg, Ilse Hernandez-Aguirre…·Kevin A. Cassady
This study develops an oncolytic HSV expressing IL-27 (C027) that improves survival in syngeneic glioma models by enhancing CD8 T cell function and inducing durable immune memory.
6 citations